GlassScriptPhysician profile
Laura M Cavin
NPI 1467739086
$1,055.02
in general payments reported to CMS, 2019-2025
17 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $271 · 2023: $200 · 2024: $100 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $304.69 | 2021-2025 | Slynd |
| Abbvie INC. | $158.61 | 2021-2023 | |
| Mylan Pharmaceuticals INC. | $80.65 | 2021-2022 | |
| Evofem Biosciences, INC. | $78.60 | 2021-2022 | |
| Pfizer INC. | $70.65 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $55.05 | 2021-2022 | |
| Therapeuticsmd, INC. | $49.99 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $49.38 | 2021-2023 | Gardasil 9 |
| Organon LLC | $39.92 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $39.73 | 2023 | Twirla |
| Hologic Sales and Service, LLC | $27.91 | 2024 | Acessa Provu System |
| Novo Nordisk INC | $21.48 | 2023 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $19.47 | 2025 | |
| Myovant Sciences INC. | $15.61 | 2022 | |
| Millicent US INC | $14.73 | 2025 | Intrarosa, Femring |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $14.41 | 2023 | Accrufer |
| Avion Pharmaceuticals | $14.14 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Cavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.